Prescription drug · ANDA
Venlafaxine NDC 70771-1650
Venlafaxine hydrochloride 75 mg/1 · Tablet, Extended release · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1650-1 | 70771165001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1650-1)Marketed from Sep 1, 2022 | |
| 70771-1650-3 | 70771165003 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1650-3)Marketed from Sep 1, 2022 | |
| 70771-1650-9 | 70771165009 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1650-9)Marketed from Sep 1, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Venlafaxine
- Generic name (nonproprietary)
- venlafaxine
- Active ingredients
- Venlafaxine hydrochloride — 75 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215622
- Marketing start
- Listing expires
- Other FDA classes
- Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1650_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57SPL ID 0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57SPL set ID 750333ce-a512-42e1-b9e3-179714b488dfRxCUI 808744, 808748, 808751, 808753UNII 7D7RX5A8MO
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771165001followed by a unit qualifier and the quantityPackage 70771-1650-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 215622
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1649 |
| Venlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1651 |
| Venlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1350 |
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1348 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1349 |
| Venlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1352 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4566 |
| Venlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1652 |